BRIEF-Zeltia SA's soft tissue sarcoma drug submitted to U.S. FDA

* Said on Monday Janssen Research & Development LLC submitted a New Drug Application (NDA) for Yondelis to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS)